GoodRx Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GoodRx Holdings generated cash of $138,292,000, which is less than the previous year. Cash used in financing activities reached the amount of -$167,395,000 last year. Net change in cash is therefore -$84,869,000.
Cash Flow
| 2018 | 45.25M | -3.45M | -24.73M |
|---|---|---|---|
| 2019 | 83.28M | -37.05M | -54.78M |
| 2020 | 131.34M | -91.61M | 905.81M |
| 2021 | 178.77M | -178.73M | -30.52M |
| 2022 | 146.78M | -210.49M | -120.22M |
| 2023 | 138.29M | -55.76M | -167.39M |
GDRX Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 757.16M | 941.10M | 971.59M | 26.05M | 34.6M | 17.53M |
Operating activities | ||||||
Net income | -8.86M | -32.82M | -25.25M | -293.62M | 66.04M | 43.79M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 111.77M | 54.17M | 34.53M | 18.43M | 13.57M | 9.80M |
Stock-based compensation expense | 104.82M | 120.23M | 160.46M | 397.28M | 3.74M | 1.76M |
| Deferred income tax benefit | 104.82M | 120.23M | 160.46M | 397.28M | 3.74M | 1.76M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -26.46M | 1.37M | -43.94M | -16.13M | -14.51M | -12.84M |
Inventories | 0 | 0 | 0 | -21.34M | 9.01M | -2.55M |
Accounts payable | 17.45M | -874K | 4.20M | 2.15M | 515K | 665K |
Cash generated by operating activities | 138.29M | 146.78M | 178.77M | 131.34M | 83.28M | 45.25M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.04M | -55.21M | -34.45M | -35.82M | -5.74M | -3.45M |
Acquisitions Net | 0 | -155.28M | -144.27M | -55.79M | -31.30M | 0 |
Cash generated by investing activities | -55.76M | -210.49M | -178.73M | -91.61M | -37.05M | -3.45M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 35.02M | 991.79M | 1.62M | 740.35M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -1.34B |
Repurchases of common stock | -103.97M | -101.72M | -57.68M | -78.71M | 0 | 0 |
Repayments of term debt | -5.27M | -7.02M | -7.02M | -35.02M | -57.23M | -294.93M |
Cash used in financing activities | -167.39M | -120.22M | -30.52M | 905.81M | -54.78M | -24.73M |
Net Change In Cash | -84.86M | -183.94M | -30.48M | 945.54M | -8.55M | 17.06M |
Cash at end of period | 672.29M | 757.16M | 941.10M | 971.59M | 26.05M | 34.6M |
| Data source | Data source | Data source | Data source |